Clinical Trial Cuts Heart Attack Risk 30% for 70+

A major new clinical trial is reshaping how doctors think about statins for older adults. The STAREE trial, presented at the European Society of Cardiology Congress 2026, found that healthy adults over 70 who took a daily statin had 30% fewer major cardiovascular events than those on a placebo. For the millions of seniors wondering whether cholesterol medication is worth starting later in life, the answer just got a lot clearer.

Why This Matters to You

If you’re over 70 and have never had a heart attack or stroke, you may have assumed statins were mainly for younger patients or people with existing heart disease. The STAREE trial challenges that assumption directly. Researchers followed nearly 10,000 adults aged 70 and older with no history of cardiovascular disease, diabetes, or dementia for almost six years. Major cardiovascular events — including heart attack, stroke, and heart-related death — occurred in just 6.0% of the statin group compared to 8.3% of the placebo group. That gap matters at an age when heart disease risk climbs every year, and it gives readers a real evidence base for a conversation many have been putting off with their doctor.

Key Facts & Context

The STAREE trial enrolled 9,971 community-dwelling older adults, randomly assigning them to either 40 mg of atorvastatin daily or a placebo. Over a mean follow-up of 5.9 years, the statin group saw a 30% relative reduction in major cardiovascular events. Importantly, the trial found no improvement in disability-free survival, and statin users experienced somewhat higher rates of muscle, liver, and diabetes-related side effects, though serious adverse events were balanced between groups overall.

• 9,971 adults 70+ enrolled, none with prior heart disease
• 30% relative reduction in major cardiovascular events
• 5.9 years average follow-up period

Cardiologists note this doesn’t mean every older adult needs a statin — it means the decision should be based on individual heart risk, not age alone, especially as newer options like PCSK9 inhibitors also gain ground.

What This Means for You

The findings give patients and doctors a clearer, more current framework for a decision that affects millions of adults 50 and older.

Talk to Your Doctor About Your Numbers

Ask your doctor for an updated cholesterol panel and a cardiovascular risk assessment before your next visit. The STAREE results are most relevant if you’re over 70 with no prior heart attack or stroke — your personal risk factors, not your birthday alone, should guide the conversation about starting or continuing a statin.

Weigh Benefits Against Side Effects

Statins aren’t risk-free. The trial found slightly higher rates of muscle pain, liver enzyme changes, and new diabetes diagnoses among statin users. If you already take a statin and tolerate it well, this trial reinforces staying the course; if you’re statin-naive, ask your doctor to weigh your specific heart risk against these known trade-offs.

Keep Up Preventive Habits Regardless

Medication is one tool, not a substitute for movement, nutrition, and regular checkups. Pairing any statin decision with consistent at-home health monitoring makes it easier to catch changes early.

Looking Forward

The STAREE trial won’t be the last word on statins for older adults, but it gives doctors and patients a clearer, more current picture than decades-old guidance offered. As more trials focused on adults over 70 emerge, expect cholesterol treatment guidelines to become more personalized rather than one-size-fits-all. For now, the smartest move is a direct conversation with your physician about your own heart risk. For related coverage, see Seasoneds’ reporting on breakthrough therapies changing care for older adults and the new mRNA vaccine offering hope against skin cancer.